WO2002007717A1 - Emulsion de composes organiques perfluores utilises a des fins medicales, procede de fabrication et procedes de traitement et de prevention des maladies au moyen de cette emulsion - Google Patents
Emulsion de composes organiques perfluores utilises a des fins medicales, procede de fabrication et procedes de traitement et de prevention des maladies au moyen de cette emulsion Download PDFInfo
- Publication number
- WO2002007717A1 WO2002007717A1 PCT/RU2000/000309 RU0000309W WO0207717A1 WO 2002007717 A1 WO2002007717 A1 WO 2002007717A1 RU 0000309 W RU0000309 W RU 0000309W WO 0207717 A1 WO0207717 A1 WO 0207717A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- emulsion
- mixture
- amine
- πeρφτορ
- πρi
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S516/00—Colloid systems and wetting agents; subcombinations thereof; processes of
- Y10S516/924—Significant dispersive or manipulative operation or step in making or stabilizing colloid system
- Y10S516/929—Specified combination of agitation steps, e.g. mixing to make subcombination composition followed by homogenization
Definitions
- Emulsion of pharmaceutical compounds for medical purposes the methods for its use and the treatment and the treatment of diseases with its use.
- the invention is subject to the medical field and the composition and method of obtaining the pharmaceutical emulsions is related to the medical industry.
- the binary emulsion of the patented product ⁇ 2088217 is the closest to the declared component of the components. ⁇ na s ⁇ de ⁇ zhi ⁇ mixture bys ⁇ vyv ⁇ dyascheg ⁇ sya li ⁇ iln ⁇ g ⁇ ⁇ e ⁇ ugle ⁇ da ⁇ e ⁇ de ⁇ alina (P ⁇ D) or ⁇ e ⁇ ilb ⁇ mida and medlenn ⁇ vyv ⁇ dyascheg ⁇ sya li ⁇ bn ⁇ g ⁇ ⁇ e ⁇ i ⁇ vann ⁇ g ⁇ ⁇ e ⁇ ichn ⁇ g ⁇ amine ⁇ e ⁇ - ⁇ - (4-me ⁇ iltsi ⁇ l ⁇ ge ⁇ sil) - ⁇ i ⁇ e ⁇ idina (P ⁇ TSP) in s ⁇ n ⁇ shenii 40-50 ⁇ b.% ⁇ 1-10 ⁇ b.% And stabilized by phospholipids, the content of livestock constitutes 2% of the total.
- E ⁇ i sv ⁇ ys ⁇ va d ⁇ s ⁇ igayu ⁇ sya on account of the introduction of the mixture ⁇ a ⁇ eln ⁇ g ⁇ dvu ⁇ vid ⁇ v zhid ⁇ i ⁇ P ⁇ S in v ⁇ dny ⁇ as ⁇ v ⁇ s ⁇ abilizi ⁇ uyuscheg ⁇ agen ⁇ a, ch ⁇ ⁇ ed ⁇ v ⁇ aschae ⁇ ⁇ yavlenie ma ⁇ s ⁇ iches ⁇ y g ⁇ anitsy ⁇ azdela ⁇ az, uvelichivae ⁇ v ⁇ emya and l ⁇ ve ⁇ n ⁇ s ⁇ i ⁇ n ⁇ a ⁇ a P ⁇ S and s ⁇ abilizi ⁇ uyuscheg ⁇ agen ⁇ va on s ⁇ adii ⁇ lucheniya ⁇ edemulsii.
- the sub-emulsion is obtained in a two-way system of homogenization in the process of 12-second recirculation in the generator of the homogenization.
- S ⁇ glasn ⁇ ⁇ isaniyu iz ⁇ b ⁇ e ⁇ eniya ⁇ e ⁇ vy and v ⁇ y ⁇ n ⁇ u ⁇ y g ⁇ m ⁇ geniza ⁇ a is ⁇ lzuyu ⁇ sya ⁇ e ⁇ emenn ⁇ , ch ⁇ zamedlyae ⁇ ⁇ tsess g ⁇ m ⁇ genizatsii, ⁇ a ⁇ ⁇ a ⁇ v ⁇ zv ⁇ a ⁇ of v ⁇ g ⁇ ⁇ n ⁇ u ⁇ a in ⁇ e ⁇ vy ⁇ iv ⁇ di ⁇ ⁇ ⁇ adaniyu already in -izmelchennuyu ⁇ n ⁇ dis ⁇ e ⁇ snuyu emulsion ⁇ u ⁇ ny ⁇ chas ⁇ its ⁇ edemulsii and - even ⁇ a ⁇ el P ⁇ S, n
- D ⁇ ug ⁇ y task ⁇ edlagaem ⁇ g ⁇ iz ⁇ b ⁇ e ⁇ eniya yavlyae ⁇ sya ⁇ az ⁇ ab ⁇ a ⁇ a ⁇ g ⁇ s ⁇ s ⁇ ba ⁇ lucheniya ⁇ edemulsii and s ⁇ bs ⁇ venn ⁇ submi ⁇ nn ⁇ y emulsion ⁇ y ⁇ i s ⁇ anenii vys ⁇ y m ⁇ n ⁇ dis ⁇ e ⁇ sn ⁇ s ⁇ i sis ⁇ emy and ⁇ i zadann ⁇ m mal ⁇ m ⁇ azme ⁇ e chas ⁇ its ⁇ e ⁇ ya ⁇ s ⁇ vue ⁇ ⁇ b ⁇ az ⁇ vaniyu ⁇ e ⁇ e ⁇ isny ⁇ s ⁇ edineny in ⁇ tsesse ⁇ ig ⁇ vleniya emulsion and its ⁇ i ⁇ anenii.
- a further one object of the invention is to reduce the cost, simplify and accelerate the process of
- ⁇ ⁇ aches ⁇ ve bys ⁇ vyv ⁇ dyascheg ⁇ sya ⁇ e ⁇ ugle ⁇ da is ⁇ lzue ⁇ sya mixture of cis and ⁇ ans iz ⁇ me ⁇ v ⁇ e ⁇ de ⁇ alina or ⁇ e ⁇ ilb ⁇ mid
- ⁇ aches ⁇ ve medlenn ⁇ vyv ⁇ dyascheg ⁇ sya P ⁇ S is ⁇ lzue ⁇ sya ⁇ e ⁇ - ⁇ -4- ( methylcyclohexyl) -pyrperidine.
- a stabilizing agent is used that is compatible with polysynthylene with a mass of 6-10 thousand Yes.
- the ratio of the mixture of converted carbons and converted amines is 2: 1 or 3: 1.
- a preferred variant of the ratio of the speed and slow-outgoing software is 2: 1. Composition of a composite polymer with polyoxypropylene with a mass of 8 thousand. Yes, it makes up 4%, when it comes to blocks 8
- P ⁇ i is ⁇ lz ⁇ vanii emulsion ⁇ iv ⁇ ishemiches ⁇ y zaschi ⁇ y ⁇ lyuchenn ⁇ g ⁇ ⁇ ⁇ v ⁇ a se ⁇ dtsa in ⁇ tsesse ⁇ a ⁇ ma ⁇ - ⁇ l ⁇ d ⁇ v ⁇ y ⁇ a ⁇ di ⁇ legii v ⁇ dn ⁇ -s ⁇ lev ⁇ y ⁇ as ⁇ v ⁇ s ⁇ de ⁇ zhi ⁇ 102 m ⁇ ⁇ aS ⁇ , 5.2 m ⁇ ⁇ S ⁇ 1.8 m ⁇ ⁇ dS1 2, 7.7 m ⁇ ⁇ a ⁇ S ⁇ z, 1.65 m ⁇ ⁇ a ⁇ 2 40 4 , and 11 omb ⁇ B-glucose, 5 formulate ⁇ preparation sodium 5 m ⁇ -sodium, 5 m succinate, 5 m glutamate, 5 m Georgia.
- toxicity is caused not by their appearance, but by the presence of imperfections. If the latter are not available, then the following.
- the factors that are responsible for the toxicity are the concentration of the ions in the second phase, the active substances are stabilized, the presence of emulsions is present.
- the cause of the death of large livestock, for example, people who live in Ukraine may be as follows from the data listed in the table.
- ⁇ nas ⁇ yaschee v ⁇ emya for ⁇ ig ⁇ vleniya emulsions bys ⁇ vyv ⁇ dyaschi ⁇ sya P ⁇ S is ⁇ lzuyu ⁇ sya d ⁇ g ⁇ s ⁇ yaschie ⁇ s ⁇ li ⁇ idy bi ⁇ l ⁇ giches ⁇ g ⁇ ⁇ is ⁇ zhdeniya having vys ⁇ e s ⁇ ds ⁇ v ⁇ ⁇ li ⁇ ilnym P ⁇ S and ⁇ ebuyuschie d ⁇ lni ⁇ elny ⁇ d ⁇ bav ⁇ an ⁇ i ⁇ sidan ⁇ v for ⁇ ed ⁇ v ⁇ ascheniya ⁇ e ⁇ e ⁇ isn ⁇ g ⁇ ⁇ isleniya.
- ⁇ aya task ⁇ eshae ⁇ sya ⁇ em, ch ⁇ in izves ⁇ n ⁇ m s ⁇ s ⁇ be ⁇ ig ⁇ vleniya emulsion P ⁇ S, v ⁇ lyuchayuschem mixing de ⁇ i ⁇ genizi ⁇ vanny ⁇ ⁇ m ⁇ nen ⁇ v ⁇ u ⁇ em ⁇ us ⁇ aniya zhid ⁇ i ⁇ P ⁇ S che ⁇ ez v ⁇ dny ⁇ as ⁇ v ⁇ s ⁇ abilizi ⁇ uyuscheg ⁇ agen ⁇ a and mn ⁇ g ⁇ a ⁇ nuyu g ⁇ m ⁇ genizatsiyu ⁇ luchenn ⁇ y mixture in dvu ⁇ n ⁇ u ⁇ n ⁇ m g ⁇ m ⁇ geniza ⁇ e vys ⁇ g ⁇ pressure s ⁇ glasn ⁇ iz ⁇ b ⁇ e ⁇ eniyu, ⁇ e ⁇ ed mixing ⁇ m ⁇ nen ⁇ v mixture zhid ⁇ i ⁇ P ⁇ S and v ⁇ dn
- FIG. 1 iz ⁇ b ⁇ azhae ⁇ ⁇ az ⁇ vye diag ⁇ ammy ⁇ em ⁇ e ⁇ a ⁇ u ⁇ a-s ⁇ s ⁇ av dvu ⁇ m ⁇ nen ⁇ ny ⁇ sis ⁇ em P ⁇ S-ge ⁇ san where ⁇ ⁇ si ⁇ dina ⁇ ⁇ l ⁇ zhena ⁇ em ⁇ e ⁇ a ⁇ u ⁇ a in g ⁇ adusa ⁇ C and ⁇ abscissa ⁇ si - d ⁇ lya P ⁇ S in dvu ⁇ m ⁇ nen ⁇ n ⁇ y sis ⁇ eme in ⁇ n ⁇ si ⁇ elny ⁇ edinitsa ⁇ ; ⁇ ig.
- the essence of the patented method is illustrated in Fig. 2, where the homogenization with the first switch and the second switch is shown schematically.
- the first switch includes a variable speed control 1 with a high speed agitator 2, camera 3 high 14
- the temperature of the process inlet 1 is transferred to the humidifier, the water is charged to the stabilized agent, which is saturated with carbon dioxide, and the temperature is not higher than that of After the cooling of the solution, the stabilizing agent is inaccessibly delivered to the negatively and with the included high-speed agitator 2, the mixture is sterilized, gas-cooled.
- the process of homogenization is ideal for the simple cooling of the process and the blowing of carbon dioxide in the process.
- Za ⁇ em in ⁇ ea ⁇ 5 ⁇ i v ⁇ lyuchenn ⁇ y meshal ⁇ e 6 ⁇ dayu ⁇ s ⁇ e ⁇ ilny a ⁇ i ⁇ genny v ⁇ dn ⁇ - s ⁇ lev ⁇ y ⁇ as ⁇ v ⁇ ( ⁇ 55) and ⁇ sle ⁇ avn ⁇ me ⁇ n ⁇ g ⁇ ⁇ e ⁇ emeshivaniya eg ⁇ emulsion
- P ⁇ edlagae ⁇ sya is ⁇ lz ⁇ va ⁇ ⁇ luchennuyu us emulsion ⁇ mim ⁇ ⁇ e ⁇ echislenny ⁇ above ⁇ imeneny to treat v ⁇ zdushn ⁇ -zhi ⁇ v ⁇ y emb ⁇ lii s ⁇ sud ⁇ v, ⁇ bli ⁇ e ⁇ i ⁇ uyuschih zab ⁇ levany s ⁇ sud ⁇ v ⁇ nechn ⁇ s ⁇ ey for de ⁇ si ⁇ atsii ⁇ i ⁇ avlenii li ⁇ ilnymi ⁇ siches ⁇ imi s ⁇ edineniyami and ⁇ ila ⁇ i ⁇ i ⁇ siches ⁇ i ⁇ ⁇ azheny, vyzyvaemy ⁇ ⁇ azlichnymi ⁇ sen ⁇ bi ⁇ i ⁇ ami.
- ⁇ ⁇ e ⁇ m ⁇ s ⁇ a ⁇ i ⁇ uemy ⁇ ea ⁇ 1 was poured 1.8 l of 10% -n ⁇ g ⁇ s ⁇ e ⁇ iln ⁇ g ⁇ v ⁇ dn ⁇ g ⁇ ⁇ as ⁇ v ⁇ a s ⁇ abilizi ⁇ uyuscheg ⁇ agen ⁇ a with m ⁇ le ⁇ ulya ⁇ n ⁇ y mass ⁇ y 8000 Yes nasyschenn ⁇ g ⁇ ugle ⁇ islym gaz ⁇ m, ⁇ g ⁇ evali in ⁇ echenie 12 chas ⁇ v ⁇ i ⁇ em ⁇ e ⁇ a ⁇ u ⁇ e 70 ° C and ⁇ sle ⁇ lazhdeniya ⁇ as ⁇ v ⁇ a s ⁇ abilizi ⁇ uyuscheg ⁇ agen ⁇ a v ⁇ lyuchali vys ⁇ s ⁇ s ⁇ nuyu meshal ⁇ u 2 and two 200 ml of a mixture of stable antipyrogenic and saturated with carbon dioxide gas, which is a constituent of rapidly emitted,
- the average diameter of the particles of the obtained emulsion PF ⁇ C is 0.07 ⁇ m, for particles of 0.2–0.3 ⁇ m diameter it was 0.9%.
- the value of Lb 5 o for mice was 150 ml per kg body weight.
- An apiogenic emulsion of PF ⁇ C was obtained, and the concentration of primary compounds of 75 ⁇ C was concentrated.
- the survival rate after intramuscular administration of 20 ml of PFOS emulsion per kg was 100% over 90 days of observation.
- the emulsion was used to accommodate 55% of the room for the dog and for 65% of the place for the body. Survival rate was 100%.
- the emulsion was obtained as described in Example 2, and was used as a component of the process to exclude the use of the device.
- the storage time for the front end of the pressure switch (for the development of the channel outlet) was 36 hours.
- the emulsion was changed every 9 hours.
- the value of LD 5 ⁇ for mice is 130 ml per kg of body weight.
- the end of the connection is 100 microns.
- the emulsion was used for pharmacological treatment.
- the heart of the dog was isolated in a single heart-lung preparation and cooled down to 1 ° C with a PF ⁇ S emulsion for 30 minutes.
- the electrical and responsive activity of the heart was restored during transplantation without additional electrical stimulation, and in two cases, In all cases, no evidence of heart failure was observed.
- EXAMPLE 6 Method of treatment of an impaired vessel of endangered vessels.
- the food processing unit was produced as a result of the processing of food products enriched with food.
- the process was divided into process equipment in the end, and with the help of 20
- non-invasive sensors divided the dynamics of the partial pressure of oxygen ( ⁇ 0 2 ) in the thighs and the extremities of the posterior end.
- erythrolylglucin a known active therapeutic agent
- a method for treating toxic diseases caused by lipid compounds was used as a component that collects loose compounds in the consumer, for example, Due to this, their active concentration decreases and the accumulation in the fabric slows down.
- Dozens of russes weighing 250–290 g introduced an estimated dose of 33% of the ethanol product in the dose of 4 g of ethanol per kg body weight - 8 live bones.
- Table 3 The production of some oil in liquid lipids of olive oil and membranes of erythrocytes at 37 ° C.
- Impurities of PFD and impurities of PFSP are listed in the process of writing a preferred embodiment of the invention.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002513453A JP2004504344A (ja) | 2000-07-20 | 2000-07-20 | 医療目的の為のペルフルオロ有機化合物の乳濁液、前記乳濁液を生産する為の方法並びに当該乳濁液の助けにより疾患を治療及び予防する為の方法 |
RU2001126062/14A RU2206319C2 (ru) | 2000-07-20 | 2000-07-20 | Эмульсия перфторорганических соединений для медицинских целей, способ ее приготовления и способы лечения и профилактики заболеваний с ее использованием |
PCT/RU2000/000309 WO2002007717A1 (fr) | 2000-07-20 | 2000-07-20 | Emulsion de composes organiques perfluores utilises a des fins medicales, procede de fabrication et procedes de traitement et de prevention des maladies au moyen de cette emulsion |
KR10-2003-7000826A KR20030039363A (ko) | 2000-07-20 | 2000-07-20 | 의료용 퍼플루오르 유기화합물의 유제 및 그 제조방법 및그것을 이용한 질병 치료 및 예방방법 |
CN008197628A CN1215834C (zh) | 2000-07-20 | 2000-07-20 | 一种用于医药目的的全氟有机化合物的乳液、其制备方法和利用其治疗和预防疾病的方法 |
US09/830,563 US6562872B1 (en) | 2000-07-20 | 2000-07-20 | Emulsion of perfluoroorganic compounds for medical purposes, a process for the preparation thereof and methods for treating and preventing diseases with the use thereof |
EP00970349A EP1306083A4 (en) | 2000-07-20 | 2000-07-20 | EMULSION OF PERFLUORIC ORGANIC COMPOUNDS USED FOR MEDICAL PURPOSES, METHOD OF MANUFACTURE AND METHODS OF TREATMENT AND PREVENTION OF DISEASES USING THE EMULSION |
AU2000279747A AU2000279747A1 (en) | 2000-07-20 | 2000-07-20 | Emulsion of perfluororganic compounds for medical purposes, method for producingsaid emulsion and methods for curing and preventing diseases with the aid of the emulsion |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/RU2000/000309 WO2002007717A1 (fr) | 2000-07-20 | 2000-07-20 | Emulsion de composes organiques perfluores utilises a des fins medicales, procede de fabrication et procedes de traitement et de prevention des maladies au moyen de cette emulsion |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002007717A1 true WO2002007717A1 (fr) | 2002-01-31 |
Family
ID=20129533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/RU2000/000309 WO2002007717A1 (fr) | 2000-07-20 | 2000-07-20 | Emulsion de composes organiques perfluores utilises a des fins medicales, procede de fabrication et procedes de traitement et de prevention des maladies au moyen de cette emulsion |
Country Status (8)
Country | Link |
---|---|
US (1) | US6562872B1 (ru) |
EP (1) | EP1306083A4 (ru) |
JP (1) | JP2004504344A (ru) |
KR (1) | KR20030039363A (ru) |
CN (1) | CN1215834C (ru) |
AU (1) | AU2000279747A1 (ru) |
RU (1) | RU2206319C2 (ru) |
WO (1) | WO2002007717A1 (ru) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2620858C1 (ru) * | 2016-04-25 | 2017-05-30 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Дагестанская государственная медицинская академия" Министерства здравоохранения РФ | Способ профилактики синдрома жировой эмболии у пострадавших с политравмой при переломах длинных трубчатых костей |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2259819C1 (ru) * | 2004-03-01 | 2005-09-10 | Кузнецова Ирина Николаевна | Эмульсия перфторорганических соединений медицинского назначения и способ её получения |
WO2008082321A1 (fr) * | 2006-12-28 | 2008-07-10 | Germanov, Evgeny Pavlovich | Émulsions de composés organiques perfluorés médicinaux, procédé de préparation et procédé d'utilisation |
CN101199548B (zh) * | 2007-12-11 | 2011-04-13 | 西安力邦医药科技有限责任公司 | 一种全氟化碳乳剂及其制备方法 |
EP2123256A1 (en) | 2008-05-19 | 2009-11-25 | Ruhr-Universität Bochum | Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer |
US8673984B2 (en) * | 2008-12-08 | 2014-03-18 | University Of Utah Research Foundation | Stable perfluorocarbon emulsion for use as an artificial oxygen carrier |
US20120039796A1 (en) * | 2010-08-15 | 2012-02-16 | Demetrios Markou | Novel method for creating, suspending and stabilizing electronically modified oxygen derivatives, along with creating, suspending and stabilizing electronically modified reaction intermediates, in a bio compatible fluorocarbon suspension, for the purpose of inducing a cascading immune response in mammalian patients |
RU2535073C1 (ru) * | 2013-07-18 | 2014-12-10 | Федеральное государственное бюджетное учреждение науки "Научно-исследовательский институт общей реаниматологии имени В.А. Неговского" Российской академии медицинских наук | Способ лечения метгемоглобинемии |
RU2557933C1 (ru) * | 2014-03-27 | 2015-07-27 | Сергей Юрьевич Пушкин | Способ приготовления стерильной наноэмульсии перфторорганических соединений |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4859363A (en) * | 1985-02-26 | 1989-08-22 | I.S.C. Chemicals Limited | Emulsions of perfluorocarbons in aqueous media |
WO1995033447A1 (en) * | 1994-06-09 | 1995-12-14 | Alliance Pharmaceutical Corp. | Stable reverse and multiple fluorocarbon emulsions |
RU2107496C1 (ru) * | 1997-02-10 | 1998-03-27 | Российская медицинская академия последипломного образования Министерства здравоохранения РФ | Способ лечения диабетической ангиопатии |
RU2122404C1 (ru) * | 1997-12-16 | 1998-11-27 | Воробьев Сергей Иванович | Способ получения эмульсии на основе перфторорганических соединений для медико-биологических целей |
US5914352A (en) * | 1992-10-27 | 1999-06-22 | Alliance Pharmaceutical Corp. | Methods for the use of stabilized fluorocarbon emulsions |
RU2144817C1 (ru) * | 1996-07-12 | 2000-01-27 | Левитан Болеслав Наумович | Способ лечения острых отравлений |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3778381A (en) * | 1972-04-24 | 1973-12-11 | Allied Chem | Fluorocarbon microemulsions |
US4369127A (en) * | 1980-07-21 | 1983-01-18 | Instrumentation Laboratory Inc. | Blood gas control |
US4775522A (en) * | 1983-03-04 | 1988-10-04 | Children's Hospital Research Foundation, A Division Of Children's Hospital Medical Center | NMR compositions for indirectly detecting a dissolved gas in an animal |
US4987154A (en) | 1986-01-14 | 1991-01-22 | Alliance Pharmaceutical Corp. | Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use |
US4866096A (en) * | 1987-03-20 | 1989-09-12 | Air Products And Chemicals, Inc. | Stable fluorochemical aqueous emulsions |
FR2679150A1 (fr) * | 1991-07-17 | 1993-01-22 | Atta | Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations. |
AU2441592A (en) * | 1991-08-08 | 1993-03-02 | Leigh D. Segel | Fluorocarbon blood substitute |
US5403575A (en) * | 1991-12-12 | 1995-04-04 | Hemagen/Pfc | Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of using them |
RU2088217C1 (ru) | 1993-05-07 | 1997-08-27 | Институт биофизики клетки РАН | Эмульсия перфторорганических соединений с газотранспортными свойствами |
FR2710840B1 (fr) * | 1993-10-04 | 1995-12-01 | Applic Transferts Technolo | Compositions viscoélastiques hautement concentrées en composés fluorés, leur préparation et leurs utilisations dans le domaine médical et en cosmétique. |
US5674913A (en) * | 1994-05-13 | 1997-10-07 | Synthetic Blood International, Inc. | Method for assisting normal breathing in a mammal having a lung disorder |
RU2070033C1 (ru) | 1994-11-28 | 1996-12-10 | Воробьев Сергей Иванович | Способ получения перфторуглеродных эмульсий для медицинских целей |
WO1997025978A1 (fr) * | 1996-01-15 | 1997-07-24 | BELOYARTSEV, Arkady Felixovich | Procede de production d'emulsions perfluorocarbonees a des fins medicales |
US5869539A (en) * | 1996-04-17 | 1999-02-09 | Board Of Regents, The University Of Texas System | Emulsions of perfluoro compounds as solvents for nitric oxide (NO) |
US6302863B1 (en) * | 1998-06-16 | 2001-10-16 | Nikolai Tankovich | Method for removal of lipids via a perfluorocarbon tumescent solution |
-
2000
- 2000-07-20 AU AU2000279747A patent/AU2000279747A1/en not_active Abandoned
- 2000-07-20 EP EP00970349A patent/EP1306083A4/en not_active Withdrawn
- 2000-07-20 KR KR10-2003-7000826A patent/KR20030039363A/ko not_active Application Discontinuation
- 2000-07-20 US US09/830,563 patent/US6562872B1/en not_active Expired - Fee Related
- 2000-07-20 WO PCT/RU2000/000309 patent/WO2002007717A1/ru active Application Filing
- 2000-07-20 CN CN008197628A patent/CN1215834C/zh not_active Expired - Fee Related
- 2000-07-20 RU RU2001126062/14A patent/RU2206319C2/ru active
- 2000-07-20 JP JP2002513453A patent/JP2004504344A/ja active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4859363A (en) * | 1985-02-26 | 1989-08-22 | I.S.C. Chemicals Limited | Emulsions of perfluorocarbons in aqueous media |
US5914352A (en) * | 1992-10-27 | 1999-06-22 | Alliance Pharmaceutical Corp. | Methods for the use of stabilized fluorocarbon emulsions |
WO1995033447A1 (en) * | 1994-06-09 | 1995-12-14 | Alliance Pharmaceutical Corp. | Stable reverse and multiple fluorocarbon emulsions |
RU2144817C1 (ru) * | 1996-07-12 | 2000-01-27 | Левитан Болеслав Наумович | Способ лечения острых отравлений |
RU2107496C1 (ru) * | 1997-02-10 | 1998-03-27 | Российская медицинская академия последипломного образования Министерства здравоохранения РФ | Способ лечения диабетической ангиопатии |
RU2122404C1 (ru) * | 1997-12-16 | 1998-11-27 | Воробьев Сергей Иванович | Способ получения эмульсии на основе перфторорганических соединений для медико-биологических целей |
Non-Patent Citations (4)
Title |
---|
IVANITSKY G.R. ET AL: "Inzhenerya isksstvennykh plazmozamenitelei krovi s gazotransportnoi fuktsei no osnove perftoruglerodnykh emulsy. B: Perfturoglerodnye aktivnye sredy dlya meditsiny i biologii (Novye aspekty issledovany)", PUSCHINO, 1993, pages 27, XP002972907 * |
POKROVSKY V.I.: "Malaya meditsinskaya entsiklopedya", MEDITSINA, vol. 6, 1996, MOSCOW, pages 359 - 360, XP002972909 * |
See also references of EP1306083A4 * |
VAICHULIS K.: "Ispolzovanie perftorana v intensivnoi alkogolnogo psikhoza. B: Fiziologicheskaya aktivnost ftorsoderzhaschikh soedineny (experiment i klinika)", PUSCHINO, 1995, pages 213 - 216, XP002972908 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2620858C1 (ru) * | 2016-04-25 | 2017-05-30 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Дагестанская государственная медицинская академия" Министерства здравоохранения РФ | Способ профилактики синдрома жировой эмболии у пострадавших с политравмой при переломах длинных трубчатых костей |
Also Published As
Publication number | Publication date |
---|---|
EP1306083A4 (en) | 2007-08-29 |
RU2206319C2 (ru) | 2003-06-20 |
EP1306083A1 (en) | 2003-05-02 |
CN1215834C (zh) | 2005-08-24 |
JP2004504344A (ja) | 2004-02-12 |
CN1454084A (zh) | 2003-11-05 |
AU2000279747A1 (en) | 2002-02-05 |
KR20030039363A (ko) | 2003-05-17 |
US6562872B1 (en) | 2003-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5650157A (en) | Pharmaceutical compositions and methods | |
JPH05503914A (ja) | 細胞増殖の抑制及びnk細胞活性の増強 | |
EP0630644A4 (en) | ANTIMICROBIAL AND INTERFERON INDUCING PHARMACEUTICAL COMPOUND. | |
WO2002007717A1 (fr) | Emulsion de composes organiques perfluores utilises a des fins medicales, procede de fabrication et procedes de traitement et de prevention des maladies au moyen de cette emulsion | |
WO1995022336A1 (fr) | Agent immunomodulateur et reducteur du dysfonctionnement du systeme de regulation de la propagation de cellules tissulaires | |
US10758578B2 (en) | Herbal formulations of carnivorous plants and methods for treating inflammation | |
CN113521050B (zh) | 含有大麻二酚的组合物及其在治疗全身炎症反应综合征中的用途 | |
WO2004043485A1 (fr) | Composition presentant des proprietes antioxydantes, procede de production d'un polypeptide et methode de traitement | |
GB2209936A (en) | Preparations for alleviating arthritis | |
RU2112504C1 (ru) | Средство для лечения заболеваний предстательной железы "витапрост" | |
JP2005330199A (ja) | 関節クリーム | |
WO1997048405A1 (fr) | Produit semi-fini permettant d'obtenir des bases de medicaments, bases de medicaments obtenues a l'aide ce dernier et variantes, et medicament faisant appel a ces bases et variantes | |
WO2001012201A1 (fr) | Composition remplacant le plasma sanguin | |
WO2005041952A1 (fr) | Composition pharmaceutique possedant une activite cerebrale vasodilatatrice et nootropique | |
CN115721607B (zh) | 一种乳酸左氧氟沙星注射液及其制备方法 | |
RU2089197C1 (ru) | Препарат пролонгированного действия и способ его получения | |
WO1994010977A1 (en) | Anti-microbial and interferon-inducing pharmaceutical compound | |
RU2145216C1 (ru) | Способ лечения хронического алкоголизма | |
RU2117485C1 (ru) | Средство для профилактики и лечения пневмоэнтеритов поросят - препарат "живая кровь" | |
Bagal et al. | Ozone therapy: An important approch in veterinary therapeutics | |
BE645942A (ru) | ||
WO1998046251A9 (en) | Immunomodulator and pharmaceutical compositions with antitumor properties, and a food additive | |
Williams | PROGRESS OF MEDICAL SCIENCE. | |
EP1369122A4 (en) | CANCER AGENT | |
Butter | On the Poisonous Effects of Nitre |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2001/003989 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09830563 Country of ref document: US |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 42/DELNP/2003 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000970349 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020037000826 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 008197628 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2000970349 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020037000826 Country of ref document: KR |